Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
53.30
-0.10 (-0.19%)
At close: Jul 17, 2025

Navana Pharmaceuticals Income Statement

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
8,4706,8985,7064,7593,6073,149
Revenue Growth (YoY)
30.23%20.89%19.91%31.95%14.53%-
Cost of Revenue
4,6003,7703,1102,5991,9931,740
Gross Profit
3,8703,1282,5962,1601,6141,409
Selling, General & Admin
2,5222,1361,8411,5911,2651,135
Operating Expenses
2,5222,1361,8411,5911,2651,135
Operating Income
1,348991.84755.72569.6348.59274.18
Interest Expense
-734.21-463.57-234.89-200.42-75.18-91.59
Interest & Investment Income
1.871.475.845.580.030.04
Currency Exchange Gain (Loss)
-39.44-25.18-33.38-93.98-2.52-5.11
Other Non Operating Income (Expenses)
13.9211.39-1.9127.6430.4722.09
EBT Excluding Unusual Items
590.58515.95491.38308.42301.39199.6
Gain (Loss) on Sale of Investments
-12.31-0.88-42.382.9-19.68
Gain (Loss) on Sale of Assets
-0.361.18-0.471.02-
Pretax Income
577.92516.25449.08391.79302.41219.28
Income Tax Expense
129.95111.6292.14117.78100.1281.88
Net Income
447.97404.63356.94274202.29137.4
Net Income to Common
447.97404.63356.94274202.29137.4
Net Income Growth
1.81%13.36%30.27%35.45%47.23%-
Shares Outstanding (Basic)
10710799808080
Shares Outstanding (Diluted)
10710799808080
Shares Change (YoY)
-0.12%8.05%23.91%---
EPS (Basic)
4.173.773.593.422.521.71
EPS (Diluted)
4.173.773.593.422.521.71
EPS Growth
1.93%4.92%5.13%35.45%47.23%-
Free Cash Flow
528.31-625.1-1,404-1,160-399181.8
Free Cash Flow Per Share
4.92-5.82-14.13-14.45-4.972.27
Dividend Per Share
1.4001.4001.3001.100--
Dividend Growth
7.69%7.69%18.18%---
Gross Margin
45.69%45.34%45.50%45.39%44.75%44.73%
Operating Margin
15.92%14.38%13.24%11.97%9.66%8.71%
Profit Margin
5.29%5.87%6.25%5.76%5.61%4.36%
Free Cash Flow Margin
6.24%-9.06%-24.61%-24.37%-11.06%5.77%
EBITDA
1,5221,163966.13675.37397.71314.49
EBITDA Margin
17.97%16.86%16.93%14.19%11.03%9.99%
D&A For EBITDA
173.97171.25210.41105.7749.1240.31
EBIT
1,348991.84755.72569.6348.59274.18
EBIT Margin
15.92%14.38%13.24%11.97%9.66%8.71%
Effective Tax Rate
22.48%21.62%20.52%30.06%33.11%37.34%
Advertising Expenses
-38.433.1380.8619.5516.63
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.